Trial
NCT04081688
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI)
Condition
Refractory Lung Non-Small Cell Carcinoma
Intervention
Atezolizumab 1200 MG in 20 ML Injection
Why stopped
accrual goal met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-05